U.S. markets closed
  • S&P Futures

    4,324.75
    +0.50 (+0.01%)
     
  • Dow Futures

    33,630.00
    -8.00 (-0.02%)
     
  • Nasdaq Futures

    14,989.50
    +4.75 (+0.03%)
     
  • Russell 2000 Futures

    1,772.40
    +1.00 (+0.06%)
     
  • Crude Oil

    88.52
    -0.30 (-0.34%)
     
  • Gold

    1,840.30
    -6.90 (-0.37%)
     
  • Silver

    21.05
    -0.37 (-1.73%)
     
  • EUR/USD

    1.0468
    -0.0013 (-0.13%)
     
  • 10-Yr Bond

    4.6830
    +0.1100 (+2.41%)
     
  • Vix

    17.61
    +0.09 (+0.51%)
     
  • GBP/USD

    1.2079
    -0.0011 (-0.09%)
     
  • USD/JPY

    149.8270
    -0.0080 (-0.01%)
     
  • Bitcoin USD

    27,515.66
    -431.51 (-1.54%)
     
  • CMC Crypto 200

    588.49
    -15.05 (-2.49%)
     
  • FTSE 100

    7,510.72
    -97.36 (-1.28%)
     
  • Nikkei 225

    31,759.88
    0.00 (0.00%)
     

Is AstraZeneca Stock a Buy for Growth Investors?

Is AstraZeneca Stock a Buy for Growth Investors?

Just 14% of drugs in development (according to a 2018 study) ever make it to market, so investing in pharmaceuticals is a bit of a shot in the dark. This is why I'd advise most investors to consider only the most dominant and established pharmaceutical companies for their portfolios. British drugmaker AstraZeneca (NASDAQ: AZN) is one such company.